Keith Suckling

Keith Suckling is a highly experienced individual with a rich background in atherosclerosis research, vascular biology, and lipid metabolism. He served as the Director and Head of Department of Atherosclerosis Research at GlaxoSmithKline until January 2006, accumulating 20 years of industry experience in addition to 14 years in academic research.

Keith has an impressive publication record, with over 100 papers in the field, and holds the esteemed Doctor of Science degree for his exceptional contributions. He was actively involved in the R&D Committee of the Association of British Pharmaceutical Industries for 7 years, demonstrating his commitment to advancing pharmaceutical research and development.

Apart from his professional pursuits, Keith has a keen interest in science education. Following his tenure at GlaxoSmithKline, he transitioned into consulting for both the pharmaceutical industry and universities, showcasing his versatility and expertise. In recognition of his expertise, he was appointed as a Special Professor in Bioethics at the University of Nottingham in 2006.

Keith's specialties lie in cardiovascular and metabolic diseases, positioning him as a leading authority in these critical areas of healthcare. His academic journey includes a PhD from the University of Cambridge and a DSc from the University of Liverpool, underlining his academic prowess and dedication to advancing scientific knowledge.

Currently, Keith Suckling is involved in various professional roles, including serving as a Priest In Charge at St Peter'S Fraserburgh within the Scottish Episcopal Church and offering consultancy services to organizations seeking his valuable insights and expertise.